46 Result(s)
within
Viviana Maestrini
Cardiology
-
Article
Open AccessCMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
-
Article
Open AccessMyocardial iron quantification using T2* and native T1map** - a 250 patient study
-
Article
Open AccessAn instantaneous ECV with no blood sampling: using native blood T1 for hematocrit is as good as standard ECV
-
Article
Open AccessLGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
-
Article
Open AccessReproducibility of native myocardial T1 map** in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance
Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is decreased in patients with Fabry disease even before left ventricular hypertrophy (LVH) occurs and may be the first non-invasive measure ...
-
Article
Open AccessT1 Map** for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure
Heart failure (HF) is a major and growing cause of morbidity and mortality. Despite initial successes, there have been few recent therapeutic advances. A better understanding of HF pathophysiology is needed wi...
-
Article
Open AccessCardiac amyloid burden assessment by T1 map** predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
-
Article
Open AccessNative T1 map** in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
-
Article
Open AccessAL and ATTR cardiac amyloid are different: native T1 map** and ECV detect different biology
-
Article
Open AccessCMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial
-
Article
Open AccessA simple technique to measure TAPSE and MAPSE on CMR and normal values
-
Article
Open AccessGlobal extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
-
Article
Open AccessT1 map** for myocardial extracellular volume measurement by cardiovascular magnetic resonance: bolus only vs primed infusion technique
-
Article
Open AccessVariable myocardial interstitial expansion by T1 map** within LGE area in infarction and hypertrophic cardiomyopathy
-
Article
Open AccessMultiorgan ECV as measured by EQ-MRI in systemic amyloidosis
-
Article
Open AccessDiffuse interstitial fibrosis in well-controlled hypertension
-
Article
Open AccessA new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy
-
Article
Open AccessNative T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease
-
Article
Open AccessNormal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI
Quantitative T1-map** is rapidly becoming a clinical tool in cardiovascular magnetic resonance (CMR) to objectively distinguish normal from diseased myocardium. The usefulness of any quantitative technique t...
-
Article
Open AccessComparison of T1 map** techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR
Myocardial extracellular volume (ECV) is elevated in fibrosis or infiltration and can be quantified by measuring the haematocrit with pre and post contrast T1 at sufficient contrast equilibrium. Equilibrium CM...
